Lee-Wen Huang1, Shiouh-Lirng Chao, Pei-Hsin Chen, Hui-Ping Chou. 1. Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital, No. 95, Wen Chang Road, Shih-Lin District, Taipei 111, Taiwan. m002057@ms.skh.org.tw
Abstract
BACKGROUND: Human papillomaviruses (HPV) have been considered to be the necessary and central agents of cervical carcinoma. OBJECTIVE: The aim of this study was to determine the prevalence and genotypes of HPV in archival cervical carcinomas. STUDY DESIGN: The study included 152 paraffin-embedded, formaldehyde-fixed cervical carcinoma specimens. To improve the detection and typing of HPV in archival tissues, we conducted a comprehensive study in which, polymerase chain reaction (PCR)-based methods using E7 type-specific (TS) and L1 modified general primers (MY11/GP6+ and GP5+/GP6+) were employed. RESULTS: Overall HPV prevalence was 98% in the cervical carcinomas. HPV 16 was detected in 66% of the tumors, HPV 18 in 22%, HPV 31 in 13%, HPV 33 in 9%, and HPV 58 in 9%. Notably, multiple HPV types were present in 44 (28.9%) of the 152 cervical carcinomas. The most common co-infections were HPV types 16/18 (12 cases), followed by HPV types 16/31 (7 cases). Additionally, HPV 18 was more frequent in adenocarcinomas and adenosquamous carcinomas (86%) than in squamous cell carcinomas (15.8%) (P = 0.0002). CONCLUSIONS: The combination of L1 general primers and E7 type-specific primers can be of use in detecting HPV DNA in archival tissues. The present study showed a high frequency of multiple HPV infections in cervical carcinomas. Hence, relevant HPV typing information in cervical carcinoma is very important for further HPV vaccine design and application.
BACKGROUND:Human papillomaviruses (HPV) have been considered to be the necessary and central agents of cervical carcinoma. OBJECTIVE: The aim of this study was to determine the prevalence and genotypes of HPV in archival cervical carcinomas. STUDY DESIGN: The study included 152 paraffin-embedded, formaldehyde-fixed cervical carcinoma specimens. To improve the detection and typing of HPV in archival tissues, we conducted a comprehensive study in which, polymerase chain reaction (PCR)-based methods using E7 type-specific (TS) and L1 modified general primers (MY11/GP6+ and GP5+/GP6+) were employed. RESULTS: Overall HPV prevalence was 98% in the cervical carcinomas. HPV 16 was detected in 66% of the tumors, HPV 18 in 22%, HPV 31 in 13%, HPV 33 in 9%, and HPV 58 in 9%. Notably, multiple HPV types were present in 44 (28.9%) of the 152 cervical carcinomas. The most common co-infections were HPV types 16/18 (12 cases), followed by HPV types 16/31 (7 cases). Additionally, HPV 18 was more frequent in adenocarcinomas and adenosquamous carcinomas (86%) than in squamous cell carcinomas (15.8%) (P = 0.0002). CONCLUSIONS: The combination of L1 general primers and E7 type-specific primers can be of use in detecting HPV DNA in archival tissues. The present study showed a high frequency of multiple HPV infections in cervical carcinomas. Hence, relevant HPV typing information in cervical carcinoma is very important for further HPV vaccine design and application.
Authors: José V Fernandes; Rosely V Meissner; Maria Gf Carvalho; Thales Aam Fernandes; Paulo Rm Azevedo; João S Sobrinho; José Cm Prado; Luisa L Villa Journal: BMC Res Notes Date: 2010-04-08
Authors: Ana M Solares; Idania Baladron; Thelvia Ramos; Carmen Valenzuela; Zaida Borbon; Sonia Fanjull; Leonardo Gonzalez; Dagnelia Castillo; Julio Esmir; Milaid Granadillo; Aileen Batte; Alberto Cintado; Mayte Ale; Maria E Fernandez de Cossio; Annia Ferrer; Isis Torrens; Pedro Lopez-Saura Journal: ISRN Obstet Gynecol Date: 2011-03-24
Authors: Maria Gabrielle de Lima Rocha; Fabio Lopes Faria; Leonor Gonçalves; Maria do Carmo M Souza; Paula Ávila Fernandes; Ana Paula Fernandes Journal: PLoS One Date: 2012-07-17 Impact factor: 3.240
Authors: Ana M Solares; Agueda Santana; Idania Baladrón; Carmen Valenzuela; Carlos A González; Alina Díaz; Dagnelia Castillo; Thelvia Ramos; Roberto Gómez; Daniel F Alonso; Luis Herrera; Hugo Sigman; Silvio E Perea; Boris E Acevedo; Pedro López-Saura Journal: BMC Cancer Date: 2009-05-13 Impact factor: 4.430